Higher GLP-1 costs lead to lower adherence
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication as prescribed, often because of high out-of-pocket costs.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
3D printing enables custom rubber gloves in smaller batches with less waste
United Kingdom
-
Novo Nordisk Foundation funds genomic research into metabolic diseases
United Kingdom
-
New AI platform could help cancer survivors get personalized support between doctor visits
United Kingdom
-
Swedish study links lower midlife cognitive scores to future strokes
United Kingdom
-
Early findings suggest stimulating multiple brain regions could enrich artificial touch
United Kingdom
-
Smartphone retinal imaging could expand global eye care screening
United Kingdom
-
Living environments and lifestyle factors may contribute to faster adult biological aging
United Kingdom
-
Case report highlights multidisciplinary approach to recurrent prostate cancer
United Kingdom